Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 2, Pages -
Publisher
Springer Nature
Online
2018-01-19
DOI
10.1038/s41419-017-0067-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
- (2016) Eya Wolfson et al. Oncotarget
- The roles of nucleolin subcellular localization in cancer
- (2015) Caroline Madeleine Berger et al. BIOCHIMIE
- Nucleolin: Dual roles in rDNA chromatin transcription
- (2015) Nathalie Durut et al. GENE
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue invasion and metastasis: Molecular, biological and clinical perspectives
- (2015) W.G. Jiang et al. SEMINARS IN CANCER BIOLOGY
- Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma
- (2015) Yona Goldshmit et al. Oncotarget
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors
- (2014) Robert Roskoski PHARMACOLOGICAL RESEARCH
- RNA-binding protein nucleolin in disease
- (2012) Kotb Abdelmohsen et al. RNA Biology
- Resistance to HER2-directed antibodies and tyrosine kinase inhibitors
- (2011) Joan T. Garrett et al. CANCER BIOLOGY & THERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Specific domains of nucleolin interact with Hdm2 and antagonize Hdm2-mediated p53 ubiquitination
- (2011) Purvi Bhatt et al. FEBS Journal
- METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells
- (2011) Guofang Zeng et al. GENE
- Nucleolin Protein Interacts with Microprocessor Complex to Affect Biogenesis of MicroRNAs 15a and 16
- (2011) Brian F. Pickering et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nucleolin on the Cell Surface as a New Molecular Target for Gastric Cancer Treatment
- (2010) Tatsuro Watanabe et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- ERBB1 and ERBB2 Have Distinct Functions in Tumor Cell Invasion and Intravasation
- (2009) D. Kedrin et al. CLINICAL CANCER RESEARCH
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Structure-Function Analysis of Nucleolin and ErbB Receptors Interactions
- (2009) Keren Farin et al. PLoS One
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
- (2008) S. Soundararajan et al. CANCER RESEARCH
- Identification of Nucleolin as New ErbB Receptors- Interacting Protein
- (2008) Ayelet Di Segni et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More